Blood-based biomarkers, including neutrophil-to-lymphocyte ratio and circulating tumor DNA, may improve treatment response ...

Key Takeaways. Claim denials are rising due to data inaccuracies, staffing shortages, and outdated technology, with 41% of ...

His study, "Impact of More Primary Care Visits on Commercial Health Care Costs," found that more frequent routine primary ...

Hope Krebill of the Masonic Cancer Alliance at the University of Kansas Medical Center outlines patient navigation models ...

Planetary health links human well-being with ecosystem health, emphasizing biodiversity loss as a driver of respiratory ...

Experts at European Respiratory Society (ERS) Congress 2025 highlight the critical link between reduced lung function and ...

Sarah Bajorek, PharmD, BCACP, assistant chief pharmacy officer for ambulatory care at UC Davis Health, discussed how the ...

A wearable device combined with machine learning may offer a solution for continuous cough monitoring in pulmonary fibrosis patients. A wearable cough monitor generated clinically useful cough data, ...

Using biochemical markers such as estimated glomerular filtration rate (eGFR) and proteinuria improved precision, reaching accuracies near 98% when aligned with kidney disease improving global ...

The coexistence of small cell lung cancer (SCLC) and gastrointestinal (GI) malignancies is exceedingly rare. In a new review article in Cureus, investigators outlined 6 such cases and offered insights ...

Oncology pharmacists now work alongside providers to improve efficiency, patient education, and treatment outcomes, according to Scott Soefje, PharmD, MBA, BCOP.

The FDA today approved remibrutinib (Rhapsido; Novartis), a highly selective Bruton tyrosine kinase inhibitor (BTKi), for the treatment of chronic spontaneous urticaria (CSU) in patients who remain ...